Jon Jones Passed Drug Test On Night Of UFC 232

There was a lot of controversy over Jon Jones being booked for UFC 232, including the event itself getting moved to California after an atypical finding in his drug test. However, it seems he was clean the night of the fight. MMA Junkie reports that the California State Athletic Commission, which oversaw the event, announced that Jones’ test for performance enhancers and drugs of abuse on the night of UFC 232 came back negative. That includes the M3 metabolite of oral turinabol, which is what caused the event to get moved in the first place. UFC 232 happened on December 29 and Jones was tested by both CSAC and USADA. He went on to defeat Alexander Gustafsson for the UFC light heavyweight title in the main event with a third-round TKO.

Jones was also ordered to take part in a drug testing program from the Voluntary Anti-Doping Association (VADA), but those results have not been revealed. The event was moved with only six days notice due to that M3 metabolite, which resulted in a 15-month suspension after UFC 214 in 2017. USADA ruled that the atypical results weren’t due to an anti-doping violation, with experts saying it was due to a “pulsing effect” that could cause it to stay in his system for an unknown amount of time. The positive test was one of three that were found between five clean tests overall.

Jones has denied using PEDs in the past and claimed that USADA has vindicated him. He will now have an evidentiary hearing for the Nevada State Athletic Commission, which allowed him to withdraw a license application for UFC 232. NSAC Executive Director Bob Bennett said their test, taken on December 9, had an “adverse” result and NSAC will look into Jones’ case for a “measured, thoughtful, and comprehensive discussion of his anti-doping testing protocol and results and provide an opportunity for the NSAC to determine the appropriate path forward for him in Nevada.”